Recent Finacing
Recent Raise
Anthera Pharmaceuticals develops anti-inflammatory secretory phospholipase inhibitors licensed from Eli Lilly and Shionogi, advancing Varespladib and A-001 through Phase II trials for cardiovascular and sickle-cell indications.
